About us

Domestic POCT Industry Leader

Founded in April 2004 and headquartered in Shenzhen, Shenzhen Huian Bioscitech Co., Ltd. specializes in R&D, production, sales and service of in vitro diagnostic medical devices. As a national high-tech enterprise with complete certifications including NMPA GMP and SGS ISO 13485:2016, it offers the "Q-yianni®" POCT series covering multiple disease diagnostics. Its products are available across 32 Chinese regions and 21 overseas countries/regions, delivering efficient rapid testing solutions globally.

21
Years of history
8000
Company area
21
Exported countries
100%
Qualified Finished Products
About us

Products

Products

Partnering with Shenzhen Huian Bioscitech has been a game-changer for our supply chain. Their POCT products, especially the infectious disease rapid diagnostics, have exceptional accuracy. The technical support team responds swiftly whenever we have questions about product applications or certifications. Their reliable supply and consistent quality help us meet the urgent diagnostic needs of our medical institution clients seamlessly.

VICTORIA PORTER,

Purchasing Director of Lifescience Diagnostics

Shenzhen Huian Bioscitech's products are a cornerstone of our B2B offerings. The 'Q - yianni®' series, with its wide coverage of diagnostic areas, meets diverse demands from our hospital and clinic clients. Their efficient order fulfillment and after - sales service make our partnership smooth, ensuring we can deliver timely solutions to the healthcare providers we serve.

DAVID ZHANG,

General Manager of MedPlus Distribution

For our international B2B operations, Shenzhen Huian Bioscitech stands out. Their CE - certified and NMPA - approved products ease market entry across different regions. The core technologies behind their assays ensure reliable results, which is vital for building trust with our global network of medical facilities. Their commitment to quality and innovation aligns perfectly with our goal of providing top - tier diagnostic tools.

EMMA LI,

Director of Global Procurement at HealthTech Alliance

NUMBER SPEAKS

We always ready for
a challenge.

20000 +

Daily Output

Up to 20,000 units/day (7M+ annually); customized orders may reduce efficiency by 30-35%.

4 +

Core TechsR&D Strength

Leveraging monoclonal antibody & GILFA platform.

48 h

Overseas Response

Remote after-sales support within 48 hours.

1000 +

Industry Recognition

Certified as Shenzhen "Specialized, Refined, Unique & New" SME.

Got an Incredible Project Right Now?

This helps ensure quality, schedule and that we’re all working toward same goal
Market
Our Global Market
As a professional POCT (point of care testing) enterprise, our products have achieved strong sales performance across the United States, Europe, Australia, New Zealand, Chile, Brazil and beyond.

Certification

Honor Certificates